Evidence map›Paper›PMID 16261156›Full record

ArticleOncogene2006

Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway.

P Rodriguez-Viciana, C H Collins, M G Moule, M Fried

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P Rodriguez-VicianaUCSF Cancer Research Institute, 2340 Sutter Street, San Francisco, California 94115, USA.
C H Collins
M G Moule
M Fried
Cancer Research Institute · US

Funding

Polyoma Virus Disrupts ARF Signaling to p53R01CA092454 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRIED, MICHAEL · 2002 to 2011
$3.0M
ARF ACTIVATION BY POLYOMA VIRUS T-ANTIGENR01CA101967 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRIED, MICHAEL · 2003 to 2007
$1.3M
NCI NIH HHS CA101967NCI NIH HHS CA92454
6 · The paper itself

Abstract

We have isolated spontaneous mutants of polyoma virus middle T-antigen (PyMT) that do not activate the ARF-p53 pathway based on their inability to block REF52 cell division. The REF52 cells containing these mutants have a flat untransformed morphological phenotype and do not express the ARF protein. The PyMT mutations in the different cell isolates so far analysed occur at a mutational hotspot in the PyMT sequence between nucleotides 1241 and 1249, which contains nine consecutive cytosines. In one set of mutants a single cytosine was deleted, while in another mutant set an additional cytosine was inserted. Both these mutations result in frameshifts, generating altered PyMT proteins containing amino-acid sequences derived from each of the two other alternative reading frames of the polyoma virus early region. Both types of mutations result in the loss of the C-terminal PyMT region containing the membrane-binding hydrophobic region and result is mislocalization of the PyMT mutant proteins. Revertant wild-type PyMT (containing nine cytosines) was easily detected in transformants generated after infection of REF52 cells expressing high amounts of dominant negative p53 with retroviruses containing either mutation. We demonstrate that wild-type PyMT revertants are derived from mutations in the hotspot sequence of the integrated mutant PyMT sequences.

Indexed as

Frameshift MutationAmino Acid SequenceAnimalsAntigens, Polyomavirus TransformingBase SequenceCell LineChromosomal InstabilityCytosineGene Expression RegulationMolecular Sequence DataPolyomavirusRatsSequence DeletionSignal TransductionTumor Suppressor Protein p14ARFTumor Suppressor Protein p53Antigens, Polyomavirus TransformingCytosineTumor Suppressor Protein p14ARFTumor Suppressor Protein p53

Identifiers

PMID16261156
OpenAlexW2001093729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.